Frontiers | Targeting Cytokine Signaling and Lymphocyte Traffic via Small Molecules in Inflammatory Bowel Disease: JAK Inhibitors and S1PR Agonists
Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases | SpringerLink
Frontiers | Emerging Topical and Systemic JAK Inhibitors in Dermatology
Cancers | Free Full-Text | Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors—A Strategy for Hematological Malignancies?
Overview of small molecule inhibitors targeting the p38 MAPK pathway... | Download Scientific Diagram
JAK inhibitors for the treatment of autoimmune and inflammatory diseases - ScienceDirect
Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases - ScienceDirect
A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and Laboratory Monitoring | SpringerLink
Overview of the Jak inhibitors as targeted biologic therapies in... | Download Scientific Diagram
Current and future status of JAK inhibitors - The Lancet
JAK Inhibitor 瑞石生物医药有限公司
JAK inhibitors in dermatology: The promise of a new drug class. - Abstract - Europe PMC
Inhibidores de JAK: usos en dermatología. Parte 1: generalidades, aplicaciones en vitíligo y en alopecia areata | Actas Dermo-Sifiliográficas
A Dual Inhibition, a Better Solution: Development of a JAK1/TYK2 inhibitor | Journal of Medicinal Chemistry
Selective JAK inhibitors | Future Medicinal Chemistry
Inhibidores de JAK: usos en dermatología. Parte 1: generalidades, aplicaciones en vitíligo y en alopecia areata | Actas Dermo-Sifiliográficas
Frontiers | Impact of Janus Kinase Inhibition on the Treatment of Axial Spondyloarthropathies
JAK inhibitors and COVID-19 | Journal for ImmunoTherapy of Cancer
The emerging safety profile of JAK inhibitors in rheumatic disease | Nature Reviews Rheumatology
Selective Janus kinase inhibitors come of age | Nature Reviews Rheumatology
A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future? - Liu - 2021 - Arthritis & Rheumatology - Wiley Online Library
JAK-STAT pathway and JAK inhibitors: a primer for dermatologists
Janus kinase 3 inhibitor - Wikipedia
A highly selective JAK3 inhibitor is developed for treating rheumatoid arthritis by suppressing γc cytokine–related JAK-STAT signal | Science Advances
